INFORMAZIONI SU QUESTO EPISODIO
In this session recorded at CMO Summit 2022, the panel discusses:
What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes
Speakers:
Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics
What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes
Speakers:
Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di PharmaTalkRadio.
ALTRI EPISODI IN QUESTO PODCAST
For more information, visit theconferenceforum.org
For more information, visit theconferenceforum.org
As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed.
In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug deve…
For more information, go to theconferenceforum.org
For more information, visit theconferenceforum.org
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Pharma Talk Radio, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
